390 related articles for article (PubMed ID: 10727455)
1. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli.
Inaba K; Turley S; Iyoda T; Yamaide F; Shimoyama S; Reis e Sousa C; Germain RN; Mellman I; Steinman RM
J Exp Med; 2000 Mar; 191(6):927-36. PubMed ID: 10727455
[TBL] [Abstract][Full Text] [Related]
2. Transport of peptide-MHC class II complexes in developing dendritic cells.
Turley SJ; Inaba K; Garrett WS; Ebersold M; Unternaehrer J; Steinman RM; Mellman I
Science; 2000 Apr; 288(5465):522-7. PubMed ID: 10775112
[TBL] [Abstract][Full Text] [Related]
3. CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms.
Askew D; Chu RS; Krieg AM; Harding CV
J Immunol; 2000 Dec; 165(12):6889-95. PubMed ID: 11120813
[TBL] [Abstract][Full Text] [Related]
4. Antigen-unspecific B cells and lymphoid dendritic cells both show extensive surface expression of processed antigen-major histocompatibility complex class II complexes after soluble protein exposure in vivo or in vitro.
Zhong G; Reis e Sousa C; Germain RN
J Exp Med; 1997 Aug; 186(5):673-82. PubMed ID: 9271583
[TBL] [Abstract][Full Text] [Related]
5. CD1 molecules efficiently present antigen in immature dendritic cells and traffic independently of MHC class II during dendritic cell maturation.
Cao X; Sugita M; Van Der Wel N; Lai J; Rogers RA; Peters PJ; Brenner MB
J Immunol; 2002 Nov; 169(9):4770-7. PubMed ID: 12391186
[TBL] [Abstract][Full Text] [Related]
6. Major histocompatibility complex (MHC) class II-peptide complexes arrive at the plasma membrane in cholesterol-rich microclusters.
Bosch B; Heipertz EL; Drake JR; Roche PA
J Biol Chem; 2013 May; 288(19):13236-42. PubMed ID: 23532855
[TBL] [Abstract][Full Text] [Related]
7. Presentation of type B peptide-MHC complexes from hen egg white lysozyme by TLR ligands and type I IFNs independent of H2-DM regulation.
Strong BS; Unanue ER
J Immunol; 2011 Sep; 187(5):2193-201. PubMed ID: 21788443
[TBL] [Abstract][Full Text] [Related]
8. In vitro hematopoiesis produces a distinct class of immature dendritic cells from spleen progenitors with limited T cell stimulation capacity.
Quah B; Ni K; O'Neill HC
Int Immunol; 2004 Apr; 16(4):567-77. PubMed ID: 15039387
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane.
Chow A; Toomre D; Garrett W; Mellman I
Nature; 2002 Aug; 418(6901):988-94. PubMed ID: 12198549
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells constitutively present self antigens in their immature state in vivo and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis.
Wilson NS; El-Sukkari D; Villadangos JA
Blood; 2004 Mar; 103(6):2187-95. PubMed ID: 14604956
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation.
Steinman RM
Mt Sinai J Med; 2001 May; 68(3):160-6. PubMed ID: 11373688
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells regulate exposure of MHC class II at their plasma membrane by oligoubiquitination.
van Niel G; Wubbolts R; Ten Broeke T; Buschow SI; Ossendorp FA; Melief CJ; Raposo G; van Balkom BW; Stoorvogel W
Immunity; 2006 Dec; 25(6):885-94. PubMed ID: 17174123
[TBL] [Abstract][Full Text] [Related]
13. Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation.
Delamarre L; Holcombe H; Mellman I
J Exp Med; 2003 Jul; 198(1):111-22. PubMed ID: 12835477
[TBL] [Abstract][Full Text] [Related]
14. MHC class II presentation is controlled by the lysosomal small GTPase, Arl8b.
Michelet X; Garg S; Wolf BJ; Tuli A; Ricciardi-Castagnoli P; Brenner MB
J Immunol; 2015 Mar; 194(5):2079-88. PubMed ID: 25637027
[TBL] [Abstract][Full Text] [Related]
15. The mode of protein antigen administration determines preferential presentation of peptide-class II complexes by lymph node dendritic or B cells.
Guéry JC; Ria F; Galbiati F; Smiroldo S; Adorini L
Int Immunol; 1997 Jan; 9(1):9-15. PubMed ID: 9043943
[TBL] [Abstract][Full Text] [Related]
16. Control of MHC class II antigen presentation in dendritic cells: a balance between creative and destructive forces.
Villadangos JA; Schnorrer P; Wilson NS
Immunol Rev; 2005 Oct; 207():191-205. PubMed ID: 16181337
[TBL] [Abstract][Full Text] [Related]
17. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.
Dolan BP; Gibbs KD; Ostrand-Rosenberg S
J Immunol; 2006 Feb; 176(3):1447-55. PubMed ID: 16424172
[TBL] [Abstract][Full Text] [Related]
18. The pathway for MHCII-mediated presentation of endogenous proteins involves peptide transport to the endo-lysosomal compartment.
Dani A; Chaudhry A; Mukherjee P; Rajagopal D; Bhatia S; George A; Bal V; Rath S; Mayor S
J Cell Sci; 2004 Aug; 117(Pt 18):4219-30. PubMed ID: 15316082
[TBL] [Abstract][Full Text] [Related]
19. Microbial and T cell-derived stimuli regulate antigen presentation by dendritic cells in vivo.
Manickasingham S; Reis e Sousa C
J Immunol; 2000 Nov; 165(9):5027-34. PubMed ID: 11046031
[TBL] [Abstract][Full Text] [Related]
20. Distinctive maturation of in vitro versus in vivo anti-CD40 mAb-matured dendritic cells in mice.
Frleta D; Lin JT; Quezada SA; Wade TK; Barth RJ; Noelle RJ; Wade WF
J Immunother; 2003; 26(1):72-84. PubMed ID: 12514431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
